拯救脓毒症指南导向的液体复苏:实践模式评估及其对患者结局的影响
这项大型多中心回顾性队列研究纳入2018年8月至2020年11月期间就诊于19个Mayo Clinic站点急诊科、疑似脓毒症的成人患者共8414例,比较接受0–29.9 mL/kg与30.0+ mL/kg(基于理想体重)静脉液体复苏两组患者的结局。结果显示,30+ mL/kg组院内死亡和30天死亡风险更低,但ICU入住几率明显更高;经倾向评分加权后,72%的患者接受的液体量不足30 mL/kg。作者结论认为,脓毒症复苏液体量大于30 mL/kg与院内死亡、30天死亡及需要机械通气风险降低相关,其数据似乎最终支持SSC的推荐。
要点
- 在8414例疑似脓毒症急诊患者中,接受30.0+ mL/kg(理想体重)静脉液体者院内死亡和30天死亡风险低于接受0–29.9 mL/kg者。
- 液体量增加同时带来ICU入住几率明显升高。
- 30.0+ mL/kg组需要机械通气的风险降低。
- 经倾向评分加权后,72%的患者实际接受的液体量不足30 mL/kg(基于理想体重)。
- 作者认为其数据似乎最终支持拯救脓毒症运动(SSC)的30 mL/kg静脉液体推荐。
适用人群与场景
- 2018年8月至2020年11月期间就诊于美国中西部、东南部和西南部19个不同Mayo Clinic站点急诊科、疑似脓毒症的成人患者。
- 患者被分为接受0–29.9 mL/kg静脉液体与接受30.0+ mL/kg静脉液体两个队列,液体量基于理想体重。
研究设计与关键结果
- 研究类型为大型多中心回顾性队列研究,共纳入8414例疑似脓毒症患者,比较接受30 mL/kg静脉液体剂量与未接受该剂量的患者。
- 患者人口学和临床信息通过电子健康记录收集,按接受的静脉液体量分为0–29.9 mL/kg组和30.0+ mL/kg组。
- 30.0+ mL/kg剂量组观察到较低的院内死亡和30天死亡风险。
- 液体剂量增加带来更高的ICU入住几率。
- 经倾向评分加权后,72%的患者接受的液体量不足30 mL/kg(基于理想体重)。
- 30.0+ mL/kg剂量组需要机械通气的风险降低。
- 统计分析评估了液体剂量对院内死亡、30天死亡率、诊断后ICU入住、诊断后开始透析、呼吸机使用、血管活性药物使用以及ICU和住院时间的影响。
证据类型、等级与局限
- 证据类型:大型多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症复苏静脉液体剂量大于30 mL/kg与院内死亡、30天死亡及需要机械通气风险降低相关,其数据似乎最终支持SSC的30 mL/kg推荐。
- 在本研究人群中,经倾向评分加权后72%的患者接受的液体量不足30 mL/kg(基于理想体重)。
指南或共识出处
- Surviving Sepsis Campaign(SSC)指南(文中引用其30 mL/kg静脉液体复苏推荐)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Aggressive fluid resuscitation remains a cornerstone of the Surviving Sepsis Campaign (SSC) guidelines, but there is growing controversy regarding the recommended 30 mL/kg IV fluid dosage. It is contended that, in selected patients, this volume confers an increased risk of volume overload without either concomitant benefit or strong evidence in support of the recommended IV fluid dosage.
OBJECTIVES: Assessment of practice patterns and their impact on patient outcomes following the surviving sepsis guidelines for fluid resuscitation.
DESIGN: Large, multisite retrospective cohort study.
SETTING AND PARTICIPANTS: The retrospective study included all adult patients who presented to the emergency department at one of 19 different Mayo Clinic sites throughout the Midwest, Southeast, and Southwest from August 2018 to November 2020 with suspected sepsis.
MAIN OUTCOMES AND MEASURES: Eight-thousand four-hundred fourteen patients suspected to have sepsis were assessed regarding fluid resuscitation and outcomes among patients receiving 30 mL/kg IV fluid dosing compared with patients who did not. Patient demographics and clinical information were collected via electronic health records. Patients were divided into two cohorts: those who received 0-29.9 mL/kg of IV fluid and those who received 30.0+ mL/kg of IV fluid. Statistical analyses were performed to evaluate the impact of fluid dose on in-hospital death, 30-day mortality, ICU admission after diagnosis, dialysis initiation after diagnosis, ventilator use, vasopressor use, as well as ICU and hospital length of stay.
RESULTS: We observed lower in-hospital mortality and 30-day mortality risk in the 30+ mL/kg dosing group. Increased fluid dosage did, however, carry a much greater chance of ICU admission. Most patients (72% after propensity score weighting) in our population received less than 30 mL/kg fluid (based on ideal body weight).
CONCLUSIONS AND RELEVANCE: IV fluid dosing for sepsis resuscitation greater than 30 mL/kg was associated with decreased risk of in-hospital mortality, 30-day mortality, and reduced risk of requiring mechanical ventilation. Our data does ultimately seem to support the SSC recommendation.
参考来源
- Govero AB, Yarrarapu SNS, Harrison MF, et al. Surviving Sepsis Guideline-Directed Fluid Resuscitation: An Assessment of Practice Patterns and Impact on Patient Outcomes. Crit Care Explor. 2022. PMID: 35923594. doi:10.1097/CCE.0000000000000739
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。